Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-γ: Effect of dose and formulation

Vaccine

Volumn 16, Issue 5, 1998, Pages 517-521

  Griffin, K F ^a   Conway, B R ^b   Alpar, H O ^b   Williamson, E D ^a  

^a CBD Porton Down   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Interferon gamma; Poly(L)lactide microspheres; V antigen; Yersinia pestis

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG FORMULATION; ENCAPSULATION; FEMALE; IMMUNOGENICITY; INOCULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; YERSINIA PESTIS;

EID: 0032033857     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)80005-9     Document Type: Article

References (18)

1. 1 Meyer, K.F. Effectiveness of live or killed plague vaccines in man. Bull. W.H.O. 1970, 42, 653-666.
2. 2 Williamson, E.D., Eley, S.M. and Griffin, K.F. et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 1995, 12, 223-230.
3. 2+-response virulence genes. J. Bacteriol. 1991, 171, 2649-2657.
4. 4 Une, T. and Brubaker, R.R. Roles of V antigen in promoting virulence and immunity in Yersiniae. J. Immunol. 1984, 133, 2226-2230.
5. 5 Leary, S.E.C., Williamson, E.D., Griffin, K.F., Russell, P., Eley, S.M. and Titball, R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against Plague. Infect. Immun. 1995, 63, 2854-2858.
6. 6 Anderson, G.W. Jr., Leary, S.E.C. and Williamson, E.D. et al. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 1996, 64, 4580-4585.
7. 7 Morris, W., Steinhoff, M.C. and Russel, P.K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994, 12, 5-11.
8. 8 Eldridge, J.H., Hammond, C.J., Meulbroek, J.A., Stass, J.K., Gilley, R.M. and Tice, T.R. Controlled vaccine release in the gut associated lymphoid tissue. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Controlled Release 1990, 11, 205-214.
9. 9 Almeida, A.J., Alpar, H.O. and Brown, M.R.W. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly (L-lactic acid) microspheres in rats, rabbits and guinea-pigs. J. Pharm. Pharmacol. 1993, 45, 198-203.
10. 10 Beck, L.R., Cowsar, D.R., Lewis, D.H., Cosgrove, R.J., Lowry, S.L. and Epperly, T. A new long-acting microcapsule system for administration of progesterone. Fertility Sterility 1979, 31, 545-551.
11. 11 Williamson, E.D., Sharp, G.J.E. and Eley, S.M. et al. Local and systemic immune response to a microencapsulated sub-unit vaccine for plague. Vaccine 1996, 14, 1613-1619.
12. 12 Nohria, A. and Rubin, R.H. Cytokines as potential vaccine adjuvants. Biotherapy 1994, 7, 261-269.
13. 13 Conway, B.R. and Alpar, H.O. Double emulsion encapsulation of proteins as model antigens using polylactide polymers: effect of emulsifier on the microsphere characteristics and release kinetics. Eur. J. Pharm. Biopharm. 1996, 42, 42-48.
14. 14 Conway, B.R. and Alpar, H.O. Co-encapsulation of proteins into PLA microspheres. Pharm. Sci. 1996, 2, 173-176.
15. 15 Snapper, C.M., Finkelman, F.D. and Paul, W.E. Differential regulation of IgGI and IgE by synthesis of Interleukin 4. J. Exp. Med. 1988, 167, 183-196.
16. 16 Gray P.W. Interferon-Gamma (IFNγ). In: Guidebook to Cytokines and their Receptors (Ed. Nicola, N.A.). Oxford University Press, Oxford, 1994
17. 17 Mosmann, T.R. and Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996, 17, 138-146.
18. 18 Heath, A.W. and Playfair, J.H.L. Conjugation of interferon-gamma to antigen enhances its adjuvanticity. Immunology 1990, 71, 454-456.